Brexit – The Consequences for Pharmaceutical Patents and Supplementary Protection Certificates

Now that the UK has left the EU, and the transition period following this departure is over, we have a clearer view on the implications of Brexit on intellectual property rights and the consequences for UK based pharmaceutical companies. Although little has changed for UK applicants wishing to obta...

Full description

Bibliographic Details
Main Authors: Harry Melville O'Brien, Anna Louise Hatt, James Alexander Stones
Format: Article
Language:English
Published: University of Huddersfield Press 2021-05-01
Series:British Journal of Pharmacy
Subjects:
Online Access:https://www.bjpharm.org.uk/article/id/896/